Valbenazine Completed Phase 4 Trials for Tardive Dyskinesia (TD) Treatment
Indications | Status | Purpose | Phase |
---|---|---|---|
Completed | Treatment | 4 |
clinicaltrials.gov Identifier | Title | Drugs |
---|---|---|
NCT03698331 | The Potential for Clinical Dependence and Withdrawal Symptoms Associated With Valbenazine | |
NCT03891862 | Persistence of Effect and Safety of Valbenazine for the Treatment of Tardive Dyskinesia |